JPH0424329B2 - - Google Patents

Info

Publication number: JPH0424329B2
Authority: JP; Japan
Prior art keywords: molecular weight; present; skin; connective tissue; cell
Prior art date: 1985-10-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

JP60225666A

Other languages

English (en)

Japanese (ja)

Other versions

JPS6284024A (ja

Inventor

Yoshitaka Ando

Kenji Matsui

Yutaka Ando

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ichimaru Pharcos Co Ltd

Original Assignee

Ichimaru Pharcos Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-10-09

Filing date

1985-10-09

Publication date

1992-04-24

1985-10-09 Application filed by Ichimaru Pharcos Co Ltd filed Critical Ichimaru Pharcos Co Ltd

1985-10-09 Priority to JP60225666A priority Critical patent/JPS6284024A/ja

1987-04-17 Publication of JPS6284024A publication Critical patent/JPS6284024A/ja

1992-04-24 Publication of JPH0424329B2 publication Critical patent/JPH0424329B2/ja

Status Granted legal-status Critical Current

Links

239000000835 fiber Substances 0.000 claims description 18
108090000765 processed proteins & peptides Proteins 0.000 claims description 16
210000002808 connective tissue Anatomy 0.000 claims description 15
102000004196 processed proteins & peptides Human genes 0.000 claims description 13
210000002950 fibroblast Anatomy 0.000 claims description 11
239000007952 growth promoter Substances 0.000 claims 1
210000004027 cell Anatomy 0.000 description 22
230000000694 effects Effects 0.000 description 18
238000000034 method Methods 0.000 description 15
230000004663 cell proliferation Effects 0.000 description 14
239000000126 substance Substances 0.000 description 13
210000003491 skin Anatomy 0.000 description 12
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
230000010261 cell growth Effects 0.000 description 9
230000035755 proliferation Effects 0.000 description 8
102000018233 Fibroblast Growth Factor Human genes 0.000 description 7
108050007372 Fibroblast Growth Factor Proteins 0.000 description 7
239000002537 cosmetic Substances 0.000 description 7
239000003814 drug Substances 0.000 description 7
229940126864 fibroblast growth factor Drugs 0.000 description 7
239000000243 solution Substances 0.000 description 7
239000013076 target substance Substances 0.000 description 7
102000008186 Collagen Human genes 0.000 description 6
108010035532 Collagen Proteins 0.000 description 6
229920001436 collagen Polymers 0.000 description 6
239000000284 extract Substances 0.000 description 6
239000003630 growth substance Substances 0.000 description 6
102000016942 Elastin Human genes 0.000 description 5
108010014258 Elastin Proteins 0.000 description 5
230000009471 action Effects 0.000 description 5
229940079593 drug Drugs 0.000 description 5
229920002549 elastin Polymers 0.000 description 5
230000001737 promoting effect Effects 0.000 description 5
238000010998 test method Methods 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
208000014674 injury Diseases 0.000 description 4
230000003020 moisturizing effect Effects 0.000 description 4
238000000108 ultra-filtration Methods 0.000 description 4
241000271566 Aves Species 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
210000004204 blood vessel Anatomy 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
231100000135 cytotoxicity Toxicity 0.000 description 3
230000003013 cytotoxicity Effects 0.000 description 3
238000000605 extraction Methods 0.000 description 3
239000012091 fetal bovine serum Substances 0.000 description 3
238000009472 formulation Methods 0.000 description 3
230000012010 growth Effects 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
210000003041 ligament Anatomy 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000012528 membrane Substances 0.000 description 3
239000000203 mixture Substances 0.000 description 3
239000002504 physiological saline solution Substances 0.000 description 3
239000000843 powder Substances 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
230000008569 process Effects 0.000 description 3
239000000047 product Substances 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
239000007858 starting material Substances 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
230000008733 trauma Effects 0.000 description 3
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
241000700198 Cavia Species 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
235000021355 Stearic acid Nutrition 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
238000010306 acid treatment Methods 0.000 description 2
239000003513 alkali Substances 0.000 description 2
-1 alkalis Substances 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
210000001508 eye Anatomy 0.000 description 2
239000004744 fabric Substances 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
239000008213 purified water Substances 0.000 description 2
238000000926 separation method Methods 0.000 description 2
230000009759 skin aging Effects 0.000 description 2
210000001626 skin fibroblast Anatomy 0.000 description 2
239000008117 stearic acid Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
230000017423 tissue regeneration Effects 0.000 description 2
229940099259 vaseline Drugs 0.000 description 2
229920000936 Agarose Polymers 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
102000029816 Collagenase Human genes 0.000 description 1
108060005980 Collagenase Proteins 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
108010067372 Pancreatic elastase Proteins 0.000 description 1
102000016387 Pancreatic elastase Human genes 0.000 description 1
108010059712 Pronase Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
235000002597 Solanum melongena Nutrition 0.000 description 1
244000061458 Solanum melongena Species 0.000 description 1
208000007107 Stomach Ulcer Diseases 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
230000001919 adrenal effect Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
210000000436 anus Anatomy 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000003915 cell function Effects 0.000 description 1
SXPWTBGAZSPLHA-UHFFFAOYSA-M cetalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SXPWTBGAZSPLHA-UHFFFAOYSA-M 0.000 description 1
229960002424 collagenase Drugs 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
239000006071 cream Substances 0.000 description 1
231100000263 cytotoxicity test Toxicity 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
210000004207 dermis Anatomy 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
208000000718 duodenal ulcer Diseases 0.000 description 1
210000005069 ears Anatomy 0.000 description 1
238000010828 elution Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000003889 eye drop Substances 0.000 description 1
229940012356 eye drops Drugs 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
230000006870 function Effects 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
238000001641 gel filtration chromatography Methods 0.000 description 1
210000004392 genitalia Anatomy 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
229940075507 glyceryl monostearate Drugs 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
230000003779 hair growth Effects 0.000 description 1
230000035876 healing Effects 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
229940039717 lanolin Drugs 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
229940040145 liniment Drugs 0.000 description 1
239000000865 liniment Substances 0.000 description 1
229940057995 liquid paraffin Drugs 0.000 description 1
239000006210 lotion Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
210000000214 mouth Anatomy 0.000 description 1
239000007923 nasal drop Substances 0.000 description 1
229940100662 nasal drops Drugs 0.000 description 1
239000004745 nonwoven fabric Substances 0.000 description 1
230000037311 normal skin Effects 0.000 description 1
210000001331 nose Anatomy 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
239000002674 ointment Substances 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000003223 protective agent Substances 0.000 description 1
238000000751 protein extraction Methods 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000005185 salting out Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000000829 suppository Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
230000029663 wound healing Effects 0.000 description 1
230000037303 wrinkles Effects 0.000 description 1

Landscapes

Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

JP60225666A 1985-10-09 1985-10-09 結合組織繊維加水分解物から抽出してなる繊維芽細胞増殖促進剤 Granted JPS6284024A (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP60225666A JPS6284024A (ja)	1985-10-09	1985-10-09	結合組織繊維加水分解物から抽出してなる繊維芽細胞増殖促進剤

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP60225666A JPS6284024A (ja)	1985-10-09	1985-10-09	結合組織繊維加水分解物から抽出してなる繊維芽細胞増殖促進剤

Publications (2)

Publication Number	Publication Date
JPS6284024A JPS6284024A (ja)	1987-04-17
JPH0424329B2 true JPH0424329B2 (fr)	1992-04-24

Family

ID=16832875

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP60225666A Granted JPS6284024A (ja)	1985-10-09	1985-10-09	結合組織繊維加水分解物から抽出してなる繊維芽細胞増殖促進剤

Country Status (1)

Country	Link
JP (1)	JPS6284024A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7201497B2 (en) *	2004-07-15	2007-04-10	Lumination, Llc	Led lighting system with reflective board
WO2008018448A1 (fr)	2006-08-11	2008-02-14	Toyo Boseki Kabushiki Kaisha	Activateur comprenant un bio-tensioactif comme ingrédient actif, un mannosyl érythritol lipide et son procédé de préparation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59152333A (ja) *	1983-02-08	1984-08-31	パルフューム・クリスチャン・ディオール	細胞増殖の刺激方法

1985
- 1985-10-09 JP JP60225666A patent/JPS6284024A/ja active Granted

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59152333A (ja) *	1983-02-08	1984-08-31	パルフューム・クリスチャン・ディオール	細胞増殖の刺激方法

Also Published As

Publication number	Publication date
JPS6284024A (ja)	1987-04-17

Publication	Publication Date	Title
JPS63502985A (ja)	1988-11-02	角膜基質創傷の治療のための組成物
JP5981947B2 (ja)	2016-08-31	スキンクリーム
HU225490B1 (en)	2006-12-28	Extracts of shark cartilage and process for producing them
US20160206550A1 (en)	2016-07-21	Stromal dells derived conditioned medium, method of obtaining said conditioned medium compositions, formulations and applications thereof
EP0711171B1 (fr)	2002-09-04	Composition pharmaceutique ou cosmetique contenant une fraction de colostrum et son utilisation medicale
JP5588474B2 (ja)	2014-09-10	コラーゲンおよび／またはヒアルロン酸産生促進用組成物
JPH08231370A (ja)	1996-09-10	皮膚化粧料
KR20070122316A (ko)	2007-12-31	주사용 인체 연조직 충전제 및 이의 제조 방법
JPH0661262B2 (ja)	1994-08-17	細胞増殖の刺激方法
CN101730540A (zh)	2010-06-09	含有角蛋白生物材料的伤口愈合组合物
JP2002534454A (ja)	2002-10-15	加齢皮膚の徴候を処置するための組成物におけるロスマリヌス属の植物抽出物の使用
CN111420023B (zh)	2024-03-15	含i型胶原和透明质酸的复合物及制备和用途
JPH10510432A (ja)	1998-10-13	ヒドロキシプロリンに富んだタンパク質、並びにそれらを含んでいる医薬製剤及び化粧的調製物
JPH09227565A (ja)	1997-09-02	創傷治療剤
CA3053887A1 (fr)	2018-08-23	Milieux conditionnes de cellules souches pour des applications cliniques et cosmetiques
JPH0424329B2 (fr)	1992-04-24
CN113481271B (zh)	2023-07-25	一种可有效减轻皮肤晒伤的海洋生物活性肽及其制备方法和应用
JPH0450293B2 (fr)	1992-08-13
US4908206A (en)	1990-03-13	Extracts of embryonic organs, process for their preparation and pharmaceutical preparation containing them
JP2533376B2 (ja)	1996-09-11	皮膚化粧料
KR101885591B1 (ko)	2018-08-06	휴매닌 또는 이의 유사체를 유효성분으로 함유하는 창상 치료용 약학적 조성물
JPH0665041A (ja)	1994-03-08	皮膚外用剤
JP2946197B2 (ja)	1999-09-06	皮膚外用剤
EP0345974B1 (fr)	1993-12-29	Protéines à effet prolifératif de cellules et leur isolément
JPS6366124A (ja)	1988-03-24	代謝活性を有する除蛋白胸腺抽出物の製造法